Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Computational and Structural Biotechnology Journal
|
June 17, 2020
The Contorsbody, an antibody format for agonism: Design, structure, and function
Guy J Georges, Stefan Dengl, Alexander Bujotzek, et al.
Frontiers in Molecular Biosciences
|
February 14, 2022
Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
Monica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Nature Machine Intelligence
|
October 27, 2025
Predicting the conformational flexibility of antibody and T cell receptor complementarity-determining regions
Fabian C Spoendlin, Monica L Fernández-Quintero, Sai S R Raghavan, et al.
Mabs
|
April 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodies
Grégory La Sala, Katharina B Kroell, Mudita Pincha, et al.
Frontiers in Molecular Biosciences
|
March 4, 2022
Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
Monica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Nature Communications
|
April 16, 2024
The physiological interactome of TCR-like antibody therapeutics in human tissues
Estelle Marrer-Berger, Annalisa Nicastri, Angelique Augustin, et al.
Cell Chemical Biology
|
October 26, 2021
Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential
Alexander Bujotzek, Georg Tiefenthaler, Laurent Lariviere, et al.
Blood
|
July 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
Christian Augsberger, Gerulf Hänel, Wei Xu, et al.
Nature Communications
|
November 14, 2020
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities
Steven X Cho, Ina Rudloff, Jason C Lao, et al.
Blood
|
October 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma
Jan Eckmann, Tanja Fauti, Marlene Biehl, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Computational and Structural Biotechnology Journal
|
June 17, 2020
The Contorsbody, an antibody format for agonism: Design, structure, and function
Guy J Georges, Stefan Dengl, Alexander Bujotzek, et al.
Frontiers in Molecular Biosciences
|
February 14, 2022
Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
Monica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Nature Machine Intelligence
|
October 27, 2025
Predicting the conformational flexibility of antibody and T cell receptor complementarity-determining regions
Fabian C Spoendlin, Monica L Fernández-Quintero, Sai S R Raghavan, et al.
Mabs
|
April 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodies
Grégory La Sala, Katharina B Kroell, Mudita Pincha, et al.
Frontiers in Molecular Biosciences
|
March 4, 2022
Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
Monica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Nature Communications
|
April 16, 2024
The physiological interactome of TCR-like antibody therapeutics in human tissues
Estelle Marrer-Berger, Annalisa Nicastri, Angelique Augustin, et al.
Cell Chemical Biology
|
October 26, 2021
Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential
Alexander Bujotzek, Georg Tiefenthaler, Laurent Lariviere, et al.
Blood
|
July 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
Christian Augsberger, Gerulf Hänel, Wei Xu, et al.
Nature Communications
|
November 14, 2020
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities
Steven X Cho, Ina Rudloff, Jason C Lao, et al.
Blood
|
October 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma
Jan Eckmann, Tanja Fauti, Marlene Biehl, et al.
Page
of 4